Aytu Biopharma

AYTUNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$25.330 M

$2.36 +1.29%

Close of 7 Aug 2026

Revenue

$66.4M

#2655 by revenue

Earnings

-$13.6M

Loss-making

Shares outstanding

10,733,208

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#381Abvc BiopharmaABVC$27.1M
#382Actuate TherapeuticsACTU$26.4M
#383Aytu BiopharmaAYTU$25.3M
#384Actinium PharmaceuticalsATNM$25.0M
#385IGC PharmaIGC$24.6M

Where these numbers come from

Share counts and financials for Aytu Biopharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.